Related Experiment Video
Updated: Mar 25, 2026
07:58
Electrophysiological Methods to Assess Peripheral Pain Block in an Anesthetized Rat
Published on: November 21, 2025
270
Antinociception by Sigma-1 Receptor Antagonists: Central and Peripheral Effects
Luz Romero1, Manuel Merlos1, José Miguel Vela1
1Drug Discovery and Preclinical Development, ESTEVE, Parc Científic de Barcelona, Baldiri Reixac 4-8, Barcelona, Spain.
Advances in Pharmacology (San Diego, Calif.)
|February 28, 2016
Summary
Sigma-1 receptor (σ1R) antagonists reduce pain hypersensitivity by inhibiting central sensitization and peripheral inflammation. They also enhance opioid analgesia, offering a dual approach to pain management.
Area of Science:
- Neuroscience
- Pharmacology
- Pain Research
Background:
- Sigma-1 receptors (σ1Rs) modulate nociception.
- σ1R knockout mice exhibit reduced pain sensitivity.
- σ1R antagonists show antinociceptive effects, especially in chronic pain conditions.
Purpose of the Study:
- To investigate the role of σ1Rs in pain modulation.
- To explore the therapeutic potential of σ1R antagonists in pain management.
- To examine the interaction between σ1R antagonists and opioids.
Main Methods:
- Behavioral studies in animal pain models.
- Electrophysiological recordings of spinal cord activity.
- Neurochemical and molecular analyses.
- Peripheral administration of σ1R antagonists.
Main Results:
- σ1R antagonists inhibit central sensitization and augmented neuronal excitability.
- Peripheral administration of σ1R antagonists reduces inflammatory hyperalgesia.
- σ1R antagonism potentiates opioid analgesia centrally and peripherally.
Conclusions:
- σ1R antagonism is a promising strategy for treating pain hypersensitivity.
- σ1R antagonists can enhance opioid efficacy, potentially reducing opioid dosage.
- Targeting σ1Rs offers a novel approach to pain management by inhibiting pain facilitation and enhancing analgesia.
Related Concept Videos
01:25Analgesia and Pain Management
2.8K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
2.8K
01:44Nociception
34.3K
Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
34.3K
01:12Local Anesthetics: Adverse Effects
964
While local anesthetics are generally safe and well-tolerated, they can occasionally cause adverse effects that vary in severity. Local anesthetics can induce toxicity at two distinct levels. They can either produce local effects through direct contact with the neural elements or be absorbed into the bloodstream from the injection site, leading to systemic effects.
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
964
01:22Opioid Receptors: Overview
6.3K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
6.3K
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
735
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
735
01:24Local Anesthetics: Differential Sensitivity of Nerve Fibers
1.7K
Local anesthetics (LAs) block the sodium channels of nerve trunks, sensory nerve endings, and neuromuscular junctions. Although LAs can block all kinds of nerves, the sensitivity of nerve fibers differs according to nerve types and structures. LAs are known to block myelinated fibers faster than unmyelinated ones. Also, they block pain or sensory neurons at low concentrations without affecting the motor neurons involved in muscle contractions. This helps relieve labor pain without affecting the...
1.7K